BR
BioRegenx, Inc.
BRGX · OTC
$0.01 +8.33% (+$0.00)
1M +0.00%
Market Cap $6.32M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
14 /100
Expensive P/FCF 335.03x
P/S 3.58x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 253.00%
FCF growth N/A
Book val. growth N/A
Profitability
24 /100
Weak Net margin 73.80%
Op. margin 21.30%
FCF margin 1.07%
Quality
79 /100
Excellent ROA 386.56%
Asset turnover 5.24x
ROIC 22.55%
Debt
0 /100
High Int. coverage -1.24x
Current ratio 0.05x
Net debt/EBITDA N/A
Stability
13 /100
Unstable Rev. volatility 6,035.73%
EPS volatility 488.95%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BRGX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
William Resides
Employees
6
Headquarters
Chattanooga